Cargando…

Metolazone Add-On Therapy in Heart Failure: A Cohort Study from Persian Registry of Cardiovascular Disease/Heart Failure (PROVE/HF)

BACKGROUND: One of the strategies for overcoming diuretic resistance among heart failure (HF) patients is adding thiazide-type diuretics. The main aim of this article is to compare the adverse clinical outcomes, including death and re-hospitalization, among individuals suffering from severe acute de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahimi, Farzad, Vakhshoori, Mehrbod, Heidarpour, Maryam, Nouri, Fatemeh, Heshmat-Ghahdarijani, Kiyan, Fakhrolmobasheri, Mohammad, Shafie, Davood
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556116/ https://www.ncbi.nlm.nih.gov/pubmed/34721901 http://dx.doi.org/10.1155/2021/3820292

Ejemplares similares

Design and methodology of heart failure registry: Results of the Persian registry of cardiovascular disease
por: Givi, Mahshid, et al.
Publicado: (2019)

The association between platelet-to-lymphocyte ratio with mortality among patients suffering from acute decompensated heart failure
por: Heidarpour, Maryam, et al.
Publicado: (2021)

Patients Characteristics and Preliminary Outcomes of Heart Failure Registry in A Middle-Income Country: Persian Registry of Cardiovascular Disease/Heart Failure (PROVE/HF)
por: Givi, Mahshid, et al.
Publicado: (2018)

Translation, cultural adaptation, validation and reliability of Persian version of Edmonton frailty score questionnaire among Iranian heart failure individuals
por: Alaei, Hojatollah, et al.
Publicado: (2023)

Prognostic Value of Shock Index, Modified Shock Index, and Age-Adjusted Derivatives in Prediction of In-Hospital Mortality in Patients with Acute Decompensated Heart Failure: Persian Registry of Cardiovascular Disease/Heart Failure Study
por: Bondariyan, Niloofar, et al.
Publicado: (2022)

Translation, Cultural Adaptation, Validation, and Reliability of Persian-Revised Heart Failure Compliance Questionnaire
por: Vakhshoori, Mehrbod, et al.
Publicado: (2022)

Relation between Hemoconcentration Status and Readmission Plus Mortality Rate Among Iranian Individuals with Decompensated Heart Failure
por: Yadollahi Farsani, Ashkan, et al.
Publicado: (2020)

Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics
por: Yeoh, Su Ern, et al.
Publicado: (2023)

Association between the Length of Hospital Stay and 30-Day Outcomes in Patients Admitted with Acute Decompensated Heart Failure
por: Namvar, Melika, et al.
Publicado: (2023)

Effect of Lycopene Supplementation on Some Cardiovascular Risk Factors and Markers of Endothelial Function in Iranian Patients with Ischemic Heart Failure: A Randomized Clinical Trial
por: Karimian, Bahareh, et al.
Publicado: (2022)

Effect of melatonin supplementation on endothelial function in heart failure with reduced ejection fraction: A randomized, double‐blinded clinical trial
por: Hoseini, Shervin Ghaffari, et al.
Publicado: (2021)

Neutrophil to lymphocyte ratio (NLR) prognostic effects on heart failure; a systematic review and meta-analysis
por: Vakhshoori, Mehrbod, et al.
Publicado: (2023)

Effects of Metolazone Administration on Congestion, Diuretic Response and Renal Function in Patients with Advanced Heart Failure
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

Adrenal insufficiency in coronavirus disease 2019: a case report
por: Heidarpour, Maryam, et al.
Publicado: (2020)

Melatonin supplementation improves N‐terminal pro‐B‐type natriuretic peptide levels and quality of life in patients with heart failure with reduced ejection fraction: Results from MeHR trial, a randomized clinical trial
por: Hoseini, Shervin G., et al.
Publicado: (2022)

Endothelial dysfunction in patients with lone atrial fibrillation
por: Heshmat-Ghahdarijani, Kiyan, et al.
Publicado: (2020)

Association of digoxin with mortality and rehospitalization in heart failure patients treated with beta-blockers: Results from the Persian Heart Failure Patient Registry
por: Yazdi, Maryam, et al.
Publicado: (2022)

Effect of melatonin on heart failure: design for a double‐blinded randomized clinical trial
por: Sadeghi, Masoumeh, et al.
Publicado: (2020)

Coexistence of Type B Insulin Resistance and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Type 2 Diabetes Mellitus: Various Manifestations With the Same Pathophysiologic Base?
por: Heidarpour, Maryam, et al.
Publicado: (2022)

Hypophosphatemia in Coronavirus Disease 2019 (COVID-19), Complications, and Considerations: A Systematic Review
por: Fakhrolmobasheri, Mohammad, et al.
Publicado: (2022)

Prevalence of, association with, severity of, and prognostic role of serum hemoglobin level in acutely decompensated heart failure patients
por: Omoomi, Sepehr, et al.
Publicado: (2023)

Outcomes Associated With a Strategy of Adjuvant Metolazone or High‐Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis
por: Brisco‐Bacik, Meredith A., et al.
Publicado: (2018)

Comparison of multiple blood pressure frequency methods with optimum blood pressure measurement among Iranian individuals
por: Mohammadi-Dolatabadi, Alireza, et al.
Publicado: (2020)

Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF
por: Felker, G. Michael, et al.
Publicado: (2021)

Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study
por: Januzzi, James L., et al.
Publicado: (2022)

Prognostic impact of monocyte-to-lymphocyte ratio in coronary heart disease: a systematic review and meta-analysis
por: Vakhshoori, Mehrbod, et al.
Publicado: (2023)

Geographic variations in the PARADIGM-HF heart failure trial
por: Kristensen, Søren Lund, et al.
Publicado: (2016)

Persian Registry Of cardioVascular diseasE (PROVE): Design and methodology
por: Givi, Mahshid, et al.
Publicado: (2017)

Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF
por: Jhund, Pardeep S., et al.
Publicado: (2021)

Bilateral Adrenal Hemorrhage and Adrenal Insufficiency in the Context of Polycythemia Vera: A Case Report and Review of the Literature
por: Soltanmohammadi, Sara, et al.
Publicado: (2022)

The Canadian Heart Failure (CAN-HF) Registry: A Canadian Multicentre, Retrospective Study of Inpatients With Heart Failure
por: Poon, Stephanie, et al.
Publicado: (2022)

Paradigm-HF: a Paradigm Shift in Heart Failure Treatment?
por: Correia, Luis Cláudio Lemos, et al.
Publicado: (2016)

The Heart Failure Optimization Study (HF-OPT): rationale and design
por: Sanchez, R., et al.
Publicado: (2023)

Early Results of the Persian Registry of Cardiovascular Disease/Congenital Heart Disease (PROVE/CHD) in Isfahan
por: Ahmadi, Ali Reza, et al.
Publicado: (2020)

Alterations of Lipid Profile in COVID-19: A Narrative Review
por: Rezaei, Abbas, et al.
Publicado: (2022)

Differences in guideline-recommended heart failure medication between Dutch heart failure clinics: an analysis of the CHECK-HF registry
por: Linssen, G. C. M., et al.
Publicado: (2020)

Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
por: Docherty, Kieran F, et al.
Publicado: (2020)

Lung ultrasound in outpatients with heart failure: the wet‐to‐dry HF study
por: Domingo, Mar, et al.
Publicado: (2021)

Effects of Digoxin in Heart Failure (HF) With Reduced Ejection Fraction (EF)
por: Parikh, Riya R, et al.
Publicado: (2022)

Heart Failure after Laboratory Confirmed Influenza Infection (FLU-HF)
por: Sin, Phyllis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u12ai0fl8e08oeg892sm87hd60